Latest Cost Reduction News

Metroglass has reported a 5% revenue decline in its half-year results but achieved a significant reduction in net debt and improved profitability, signaling progress in its turnaround strategy amid challenging market conditions.

Metro Performance Glass reported a surprising 157% jump in net profit for H1 2025, even as revenue fell 5%, raising questions about underlying business dynamics.

HiTech Group Australia has reported its strongest financial year yet in FY25, with solid revenue growth and a robust balance sheet, while facing margin pressures in the first half of FY26 due to government spending shifts.

Coventry Group reports a challenging FY25 with revenue slipping 1.7% and EBITDA plunging 40.9%, but early FY26 results show promising recovery driven by cost cuts and ERP system stabilisation.

Oceania Healthcare reports a robust interim result for the six months to September 2025, with significant earnings growth, improved sales, and a reduction in debt gearing. The company’s strategic focus on cost control, capital management, and sustainable care delivery underpins its positive outlook despite housing market headwinds.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million for FY25, alongside an 8.1% decline in underlying NPAT, aligning with prior guidance. The company outlined a cautious FY26 outlook focused on innovation, doctor retention, and cost management.

Monash IVF Group reported solid FY25 revenue and EBITDA growth despite sector softness and clinical incidents, while announcing a leadership transition and dividend pause.

IPH Limited reported solid FY25 profit growth driven by Canadian acquisitions and a promising FY26 start despite challenges in Australia and New Zealand. CEO Andrew Blattman announced his retirement for late 2026, marking a pivotal leadership transition.

LaserBond’s 2025 AGM reveals a pivotal CEO transition alongside a strong financial rebound driven by strategic investments and technology licensing deals.

North Stawell Minerals reported a strong turnaround in FY2025 with encouraging gold exploration results at Darlington and a successful $2.4 million capital raise, setting the stage for growth.

Apiam Animal Health reported a challenging FY25 with underperformance in its core clinical segment but has rebounded strongly in Q1 FY26. The company is now poised for acquisition by Adamantem Capital, offering shareholders a premium cash and scrip deal.

Lake Resources N.L. reports significant progress on its Kachi lithium project, unveiling enhanced project economics and next-generation lithium extraction technology amid a bullish lithium market and supportive Argentine political climate.